18889881171
Company Overview: Moleculin Biotech, Inc. (NASDAQ: MBRX) is a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumours and viruses.
Published At: Mar 23, 2023 12:00 AM PDT
Published At: Mar 22, 2023 12:00 AM PDT
Published At: Jan 09, 2023 12:00 AM PST
Published At: Nov 28, 2022 12:00 AM PST
Published At: Oct 12, 2022 12:00 AM PDT
Published At: Sep 29, 2022 12:00 AM PDT
Published At: Sep 16, 2022 12:00 AM PDT
Published At: May 23, 2022 12:00 AM PDT
Published At: Feb 19, 2022 12:00 AM PST
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!